Hot topics close

Sickle cell disease

New study examines promising approach to treating attention and working memory difficulties in child
29
  • New study examines promising approach to treating attention and working memory difficulties in child
  • New study examines promising approach to treating attention and working memory difficulties in children
  • Adaptive cognitive training program can benefit children with sickle cell disease
  • Sickle Cell Anemia Therapeutics Market Outlook And Growth Stance Forecasted Through 2025
  • Sickle cell trial is changing lives in Birmingham
  • Natural Killer (NK) Cell Therapeutics Market is Estimated to Perceive Exponential Growth till 2027 || INmuneBIO ...
  • Sickle Cell Disease Treatment Market 2021 Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities till 2026 |AstraZeneca,
  • Global Sickle Cell Anemia Therapeutics Market 2020 Trending Research Report – BioMarin, Sancilio Pharmaceuticals ...
  • Global Sickle Cell Anemia Therapeutics Market 2021 Development Status, Competition Analysis, Type and Application ...
  • Evan Smith inquest: Hospital 'failure' led to sepsis patient's death
  • Patient Wouldn't Have Died if Staff Recognised Symptoms Sooner: Coroner
  • Patient, 21, died because staff did not understand sickle cell disease, inquest hears
  • Death of patient who rang 999 from hospital bed could have been prevented, coroner says
  • Gene editing treatment shows promise in sickle cell disease fight
  • Gene Editing Shows Promise in Sickle-Cell Disease
  • Sickle Cell Anemia Testing and Screening - Global Market Outlook Report 2019-2027 - ResearchAndMarkets.com
  • Sickle Cell Anemia Testing and Screening - Global Market Outlook Report 2019-2027 - ResearchAndMarkets.com
  • Fulcrum Therapeutics Announces Preclinical Proof-of-Concept Data for FTX-6058 at the Virtual 14th Annual Sickle Cell ...
  • Fulcrum Therapeutics Announces Preclinical Proof-of-Concept Data for FTX-6058 at the Virtual 14th Annual Sickle Cell ...
  • Unintentional Nonadherence to Hydroxyurea Prevalent Among Sickle Cell Patients